Diageo PLC

Diageo is a premium drinks business based in the United Kingdom. Co. is engaged in producing and distributing spirits, beer and wine. Co.'s operations include producing, distilling, brewing, bottling, packaging, distributing, developing and marketing of a range of brands. The brands that it produces and distributes include Smirnoff vodka, Johnnie Walker scotch whisky, Baileys Original Irish Cream liqueur, Captain Morgan rum, J&B scotch whisky, Tanqueray gin and Guinness stout. In addition, Co. also has the distribution rights for the Jose Cuervo tequila brands in North America and other countries.
  • TickerDGE
  • ISINGB0002374006
  • ExchangeLondon Stock Exchange
  • SectorBeverages
  • CountryUnited Kingdom

Diageo: 1 director bought

A director at Diageo bought 7,500 shares at 33.713USD and the significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board member...

Expert Corporate Governance Service (ECGS)

Diageo - AGM 28 September 2020

Elections to the Board Two Non-Executive Directors will join the Board. Sir John Manzoni was appointed Non-Executive Director from 1 October 2020 and Valérie Chapoulaud-Floquet from 1 January 2021. While their appointment has been announced by Diageo, their election is not subject to shareholder approval at the 2020 AGM, which we regret strongly. We do not consider such practice being in line with the best corporate standards. Items 4 and 21: Dividend and Share buybacks In view of the recent events relating to Covid-19, ECGS considers that it is not the right moment to increase dividend and...

DIAGEO reduced its risk exposure resulting in an upgrade to Slightly Positive

DIAGEO (GB), a company active in the Distillers & Vintners industry, reduced its market risk and raised its general evaluation. The independent financial analyst theScreener awarded an improved star rating to the company, which now shows 2 out of 4 possible stars; its market behaviour has improved and can be considered as defensive. theScreener believes that this new assessment merits an overall rating upgrade to Slightly Positive. As of the analysis date August 18, 2020, the closing price was GBp 2,630.00 and its potential was estimated at GBp 3,106.58.

Stephane Houri

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 08/05/2020

In this report we analyse the notable differences between the published results of phase I tests for COVID-19 vaccines even though, at this stage, it is difficult to compare one trial with another. Phase I results have been positive overall, in terms of both safety (primary challenge) but also efficacy, with all recording the production of neutralising antibodies. We think that the results published by BioNtech and Moderna lend even greater credibility to the mRNA approach. We are sti...

Stephane Houri

ODDO BHF SECURITIES MORNING NEWS – COMMENTAIRES DETAILLES 05/08/2020

Nous analysons ici les différences notables entre les phases 1 publiées sur le vaccin contre la COVID-19, bien qu’il soit, à ce stade, délicat de comparer une étude à une autre. Les résultats de phase 1 sont dans l’ensemble positifs en termes de sécurité (enjeu premier) mais aussi d’efficacité avec la production, pour l’ensemble, d’anticorps neutralisants. Nous croyons que les résultats de BioNtech et Moderna crédibilisent d’autant plus l’approche à ARNm. Nous maintenons notre recomma...

Matthieu DRIOL

Analyse court terme - DIAGEO : Stochastiques en zone de surachat.

La tendance est incertaine. Les cours se sont repris, mais la tendance manque de puissance pour le moment. Les Stochastiques sont en zone de surachat. Les cours pourraient se replier jusqu'à 2 498,84 p.

Matthieu DRIOL

Short term view - DIAGEO : Overbought stochastics

The trend is uncertain. Prices have recovered but the trend lacks power for the time being. Stochastics are at the overbought level. prices could fall again to 2,498.84 p.

Matthieu DRIOL

Analyse court terme - DIAGEO : La tendance est haussière.

La tendance est haussière. Les cours progressent encore, mais la tendance s'affaiblit. La prochaine résistance est à 2 769,50 p. La rupture de 2 312,04 p mettrait la tendance en danger.

Matthieu DRIOL

Short term view - DIAGEO : The trend is bullish.

The trend is bullish. Prices are still making progress but the trend is slowing down. The next resistance is at 2,769.50 p. The break of 2,312.04 p would endanger the trend.

Matthieu DRIOL

Medium term view - DIAGEO : The correction is gaining traction.

The background trend is clearly bullish. The correction is gaining traction. It is too early to qualify this action as a bearish reversal. The trend would be invalidated below the support at 2,312.04 p.

Virginie Roumage

Diageo: A solid end to the year

Diageo: (NEUTRAL, Fair Value 2340p (-18%)) A solid end to the year Full-year organic sales growth was very solid at 5%, better than expected (consensus and our estimate: +4.3%), thanks to North America and Asia Pacific. 2017/18 EBIT before exceptional items reached GBP3,819m vs consensus: GBP3,770m. The group reiterated its mid term guidance for 1/ mid single digit organic sales growth and 2/ organic EBIT margin expansion of 175bp in the three years ending 2018/19. It also announced a new share buyback program of GBP2bn in 2018/19.

Diageo: 1 director bought

A director at Diageo bought 7,500 shares at 33.713USD and the significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board member...

Fatma Agnès Hamdani ...
  • Samantha Jeary

Diageo : North America cushions the organic decline in H2. Reported EBIT heavily affected by impairments (mainly in India)

>Recap on FY 2019-20 results - Diageo yesterday morning reported its earnings for H2 and FY 2019-20. H2 sales came to £ 4,552m, 1.7% below consensus forecasts, bringing full-year sales to £ 11,752m. The group recorded an organic decline in sales of 8.2% over the full year with -22.6% in H2 (compared with -10.5% for Campari and around -28e% for Rémy Cointreau in the same half). The price mix effect is positive (+2.8% in the full year) thanks to the outperformance of No...

Fatma Agnès Hamdani ...
  • Samantha Jeary

Diageo : L’Amérique du Nord atténue la baisse organique du S2. L’EBIT publié est très impacté par des dépréciations (principalement en Inde)

>Retour sur les résultats FY 2019/20 - Diageo a publié hier matin ses résultats S2/FY 2019-20. Le CA S2 ressort à 4 552 M£, 1.7% en dessous des attentes du consensus, soit un CA annuel de 11 752 M£. Le groupe enregistre une baisse organique de ses ventes de 8.2% sur l’année, dont -22.6% sur le S2 (ce qui se compare à -10.5% pour Campari et c.-28e% pour Rémy Cointreau sur le même semestre). L’effet prix/mix est positif (+2.8% sur l’année) grâce à la surperformance de l...

Virginie Roumage

DIAGEO | BUY | 3210p US not enough to offset the drop in other regions

Full year results slightly below forecasts… … due to all regions except North America No guidance provided for 2020/21

Fatma Agnès Hamdani ...
  • Samantha Jeary

Diageo : Diageo India reported Q1 results (April-June 2020): “positive” surprise in sales but negative EBITDA and a mixed outlook

>Sales down 54% in the quarter: better than expected in our view - Diageo India released its Q1 2020-21 results yesterday (April-June 2020 which corresponds to the Diageo group’s Q4). Diageo India’s Q1 sales came to INR 10.3bn, down 51% y-o-y organic (-54% reported), i.e. a fall in the period January-June 2020 of around 32% on a reported basis relative to the same period last year, whereas we previously expected a fall of 45% in sales in India in the first half. The f...

Fatma Agnès Hamdani ...
  • Samantha Jeary

Diageo : Diageo India a publié son T1 (avril-juin 2020) : « bonne » surprise sur les ventes mais EBITDA négatif et des perspectives mitigées

>CA en baisse de 54% sur le trimestre : mieux qu’attendu selon nous - Diageo India a publié hier ses résultats T1 FY21 (avril-juin 2020, ce qui correspond au T4 du groupe Diageo). Les ventes T1 de Diageo India ressortent à 10.3 MdINR, en baisse de 51% yoy en organique (-54% en publié) soit une baisse sur la période janvier-juin 2020 de c. 32% en publié par rapport à la même période l’année dernière, alors que nous intégrions jusqu’alors une baisse de 45% du CA en Inde...

Diageo PLC: Key Facts and Statistics - H1 Dec 2016

CORPORATES ISSUER PROFILE 23 February 2017 TABLE OF CONTENTS Company Overview 1 Business Description 2 Management Strategy 4 Financial Highlights 5 Capital Structure and Debt Maturity 7 Company Management 9 Ownership Structure 10 Subsidiaries 10 Subsidiaries Rated by Moody’s 10

Diageo PLC - H1 2016: Peer Snapshot

Peer Snapshot: Diageo PLC - H1 2016 3 February 2017 (in US millions) FYE Jun-15 FYE Jun-16 LTM Dec-16 FYE Jun-14 FYE Jun-15 LTM Jun-16 FYE Apr-15 FYE Apr-16 LTM Oct-16

Stephane Houri

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 08/05/2020

In this report we analyse the notable differences between the published results of phase I tests for COVID-19 vaccines even though, at this stage, it is difficult to compare one trial with another. Phase I results have been positive overall, in terms of both safety (primary challenge) but also efficacy, with all recording the production of neutralising antibodies. We think that the results published by BioNtech and Moderna lend even greater credibility to the mRNA approach. We are sti...

Stephane Houri

ODDO BHF SECURITIES MORNING NEWS – COMMENTAIRES DETAILLES 05/08/2020

Nous analysons ici les différences notables entre les phases 1 publiées sur le vaccin contre la COVID-19, bien qu’il soit, à ce stade, délicat de comparer une étude à une autre. Les résultats de phase 1 sont dans l’ensemble positifs en termes de sécurité (enjeu premier) mais aussi d’efficacité avec la production, pour l’ensemble, d’anticorps neutralisants. Nous croyons que les résultats de BioNtech et Moderna crédibilisent d’autant plus l’approche à ARNm. Nous maintenons notre recomma...

Jean Sassus ...
  • Steven Gould

ODDO BHF SECURITIES MORNING NEWS – COMMENTAIRES DETAILLES 28/07/2020

...

Alain William ...
  • Antoine Boivin-Champeaux
  • Fatma Agnès Hamdani
  • Jean Danjou
  • Johanna Jourdain
  • Matthias Desmarais
  • Samantha Jeary
  • Yan Derocles

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 06/10/2020

ASMi’s story increasingly resembles that of ASML (minus the monopoly). The group benefits from the structural increase in capex for 7nm, 5nm and soon 3nm nodes in more precise deposition techniques (ALD and epitaxy) and is gaining market share in memory. ASMi is now profitable and has enough cash to dispense with ASM PT, which should be an incentive for it to sell its residual 25% stake. This would crystallise the group’s low valuation relative to peers (11.8x EBITDA excluding ASM PT)...

DIAGEO reduced its risk exposure resulting in an upgrade to Slightly Positive

DIAGEO (GB), a company active in the Distillers & Vintners industry, reduced its market risk and raised its general evaluation. The independent financial analyst theScreener awarded an improved star rating to the company, which now shows 2 out of 4 possible stars; its market behaviour has improved and can be considered as defensive. theScreener believes that this new assessment merits an overall rating upgrade to Slightly Positive. As of the analysis date August 18, 2020, the closing price was GBp 2,630.00 and its potential was estimated at GBp 3,106.58.

Ford Equity International Rating and Forecast Report

Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the we...

Expert Corporate Governance Service (ECGS)

Diageo - AGM 28 September 2020

Elections to the Board Two Non-Executive Directors will join the Board. Sir John Manzoni was appointed Non-Executive Director from 1 October 2020 and Valérie Chapoulaud-Floquet from 1 January 2021. While their appointment has been announced by Diageo, their election is not subject to shareholder approval at the 2020 AGM, which we regret strongly. We do not consider such practice being in line with the best corporate standards. Items 4 and 21: Dividend and Share buybacks In view of the recent events relating to Covid-19, ECGS considers that it is not the right moment to increase dividend and...

Expert Corporate Governance Service (ECGS)

Diageo - AGM 19 September 2019

Item 2: Approve the Remuneration Report The structure is weighted more towards rewarding long-term performance, but benefits and pension contributions exceed guidelines and accelerated vesting in the event of a change of control is possible. Moreover, actual and potential incentive pay is excessive and awarded amounts are excessive as compared to peers. Item 18: Approve the new Articles of Association Although the Company has provided information on key changes, they have not disclosed the new Articles.

Diageo PLC – Proxinvest Corporate Governance Rating ® : B

Proxinvest Corporate Governance Rating ® helps investors integrate governance into their investment decision and identify governance risks and opportunities within their portfolio. Proxinvest Corporate Governance Rating ® Service rates European issuers through the analysis of four main themes : Ownership & Shareholder rights, Board & Committees, Audit & Process, Remuneration. Each theme is rated taking into account several comprehensive sub-categories. Our unique two-step process to achieve each rating includes a first step quantitative valuation and a second step qualitative filter...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch